RPG Life Sciences share news, announcements and annual reports
NSE: RPGLIFEBSE: 532983Pharmaceuticals & BiotechnologySmall Cap
RPG Life Sciences Limited · Face value ₹8 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 2008
Last close ₹2,549.50down ₹26.20 (1.02%)BSE ₹2,548.10
Share price at the NSE close on 2 Nov 2026. Previous close ₹2,575.70.
2 Nov: open ₹2,562.80, high ₹2,571.90, low ₹2,480.00
52-week range of traded prices to 2 Nov 2026
₹1,733.00Low, 23 Mar 2026₹3,127.80High, 25 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹4,217 Cr923rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 38.55
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 6.14
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.94%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it, the company's own balance sheet from before it began consolidating; the two agree where both are first on record.
- 17.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 14.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.03
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 23,32627.4% delivered
RPG Life Sciences share news and announcements
681 announcements, routine notices left out, newest first. Page 13 of 14.
Aug 2012
Jul 2012
30 Jul · Board meeting
Inter alia, to consider and approve the unaudited financial results for the quarter ended June 30, 2012.25 Jul · Dividend
AGM of the Company is scheduled to be held on August 09, 2012 and the dividend, if declared, at the said AGM will be paid to the eligible members on August 20, 2012.3 Jul · Corporate action
Register of Members and Share Transfer Books of the Company will remain closed from July 26, 2012 to August 09, 2012 (both days inclusive) for the purpose of Annual General Meeting and payment of equity dividend of Rs.0.80 per share (10%) for the year ended March 31, 2012, if declared at the said Annual General Meeting.
Apr 2012
27 Apr · Board meeting
At the Board Meeting held on April 27, 2012 : (1) Mr. Dilip Sen resigned from the Directorship of the Company w.e.f. April 18, 2012; (2) Mr. C. Vinayaraghavan was appointed as Director of the Company w.e.f. April 27, 2012, in the casual vacancy caused due to the resignation of Mr. Dilip Sen; (3) Mr. R.A. Shah was appointed as Alternate Director to Mr. C. Vinayaraghavan w.e.f. April 27, 2012.27 Apr · Dividend
Board of Directors of the Company at its meeting held on April 27, 2012 has recommended an equity dividend of Rs. 0.80 per share (10%) for the year ended March 31, 2012, subject to the approval of the members at the ensuing Annual General Meeting.27 Apr · Results
13 Apr · Board meeting
Interalia, to consider and approve the following : (1) Audited Financial Results for the year ended on March 31, 2012; and (2) Recommendation of dividend for the year 2011-12, if any.
Mar 2012
Jan 2012
12 Jan · Board meeting
Inter alia, to consider and approve the unaudited financial results for the quarter ended December 31, 2011.11 Jan · Updates
Company has received a communication from the Ministry of Social and Family Affairs, Health and Consumer Protection, Hamburg, Germany not granting EU GMP for the Company's API facility at Navi Mumbai, Maharashtra post their inspection citing certain deficiencies. This has adverse impact on export business of the Company. The Company has taken immediate remedial measures, is reviewing all the issue raised by the said health authority and is working towards resolving them in a time bound manner. The Company continues to hold a valid WHO GMP and TGA, Australia certification for its facilities.
Nov 2011
17 Nov · Management
Mr. Rajesh Shirambekar has been appointed as Head - Legal and Company Secretary and Compliance Officer of the Company with effect from November 11, 2011.
Oct 2011
10 Oct · Management
Mr. Ankur Kumar, Head - Legal & Company Secretary has resigned from the services of the Company w.e.f. October 04, 2011.7 Oct · Board meeting
Inter-alia, to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2011.
Sep 2011
Aug 2011
Jul 2011
28 Jul · Results
22 Jul · Dividend
AGM of the Company is scheduled to be held on July 28, 2011 and the dividend, if declared, at the said AGM will be paid to the eligible members on August 12, 2011.8 Jul · Board meeting
Inter alia, to consider and approve the unaudited financial results for the quarter ended June 30, 2011.4 Jul · Corporate action
Register of Members and Share Transfer Books of the Company will remain closed from July 18, 2011 to July 28, 2011 (both days inclusive) for the purpose of Annual General Meeting and payment of equity dividend of Rs.1.60 per share (20%) for the year ended March 31, 2011, if declared at the said Annual General Meeting.
Apr 2011
28 Apr · Results
28 Apr · Dividend
Board of Directors of the Company at its meeting held on April 28, 2011 has recommended an equity dividend of Rs.1.60 per share (20%) for the year ended March 31, 2011, subject to the approval of the members at the ensuing Annual General Meeting.15 Apr · Board meeting
Inter alia, to consider and approve the following : (1) Audited Financial Results for the year ended on March 31, 2011; and (2) Recommendation of dividend for the year 2010-11, if any.15 Apr · Results
Company would be submitting the audited financial results for the year ended March 31, 2011 within 60 days from the end of financial year. In view of this, the Company will not be submitting / publish the unaudited financial results for the last quarter ended March 31, 2011.
Jan 2011
6 Jan · Board meeting
Inter-alia, to consider and approve the unaudited financial results for the quarter ended on December 31, 2010.
Nov 2010
2 Nov · Business
Committee of Directors at its meeting held on November 01, 2010 has issued and allotted 28,391 equity shares of Rs.8/- each under the Employees Stock Option Scheme (ESOP Scheme) pursuant to exercise of equivalent number of stock options by employees.
Oct 2010
23 Oct · Management
Mr. Sachin Raole, General Manager - Finance has been designated as Chief Financial Officer of the Company.11 Oct · Board meeting
Inter alia, to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2010.6 Oct · Management
Mr. Niraj Bajaj has resigned as Director of the Company w.e.f. October 1, 2010.
Sep 2010
Aug 2010
Jul 2010
20 Jul · Dividend
Annual General Meeting (AGM) of the Company is scheduled to be held on July 29, 2010 and the dividend, if declared, at the said AGM will be paid to the eligible members on August 12, 2010.19 Jul · Board meeting
Inter alia, to consider and approve the unaudited financial results for the quarter ended June 30, 2010.